See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · SLAS2012 1st Annual Conference & Exhibition · San Diego, California · February 4-8, 2012 · Booth 445

Research Area · Diabetes

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10010132 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester - ≥98% (isomer mixture) 2008-06-09 26.467360343769 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester 15-deoxy-Δ12,14-PGJ2-2-glycerol ester PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic 26.467360343769
11046 2-NBDG New 186689-07-6 ≥98% (mixture of α and β) 2011-10-07 50.127816964899 2-nbdg NBD-Glucose fluorescence fluorescent probes glucose uptake cells viability contrast reagents neoplasia cancers diabetes flow cytometry microscopy 213484-93-6 50.127816964899
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 120.923977900552 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 120.923977900552
589320 8-hydroxy-2-deoxy Guanosine EIA Kit - 2008-05-21 631.261328367764 8-hydroxy-2-deoxy-guanosine-eia-kit 8-OH-dG ELISA Kit; DNA Damage EIA Kit solid plates oxidative injury stress aging cancers diabetes hypertension hydroxyl radicals peroxynitrite plasmas cells lysates tissues urine creatinine LC-MS liquid DNA damage kits EIAs chormatography mass spectrometry kits enzyme immunoassays elisas 8-OH-2-d 8OH2d 8 oxo deoxyguanine deoxyguanosine hydroxy ohdg 2 EIA/ELISA assays 631.261328367764
10012708 A-922500 959122-11-3 ≥95% 2010-12-21 260.189103744628 a-922500 (1R,2R)-2-(4'-(3-phenylureido)biphenylcarbonyl)-cyclopentanecarboxylic acid triglyceride obesity insulin resistance inhibitors metabolic syndrome diacyl glycerolacyltransferase DGAT-1 DGAT1 DGAT 1inhibits inhibition A-922500 A922500 mice murine diet induced obesity DIO diet-induced Compounds, Biphenyl Biphenyl Compounds 260.189103744628
10008492 Adipose Triglyceride Lipase Blocking Peptide - 2006-06-27 8.294806629834 adipose-triglyceride-lipase-blocking-peptide ATGL; TG-hydrolase inducible PLA2-ζ; Desnutrin antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis 8.294806629834
10006409 Adipose Triglyceride Lipase Polyclonal Antibody - 2005-11-23 16.587553275453 adipose-triglyceride-lipase-polyclonal-antibody Phospholipase A2ζ; Desnutrin; ATGL antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis immunoblotting 16.587553275453
10010241 AICAR 2627-69-2 >98% 2008-02-25 144.720110497237 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 144.720110497237
10010332 AMP-Deoxynojirimycin Exclusive 216758-20-2 ≥95% ✓ 2008-11-21 32.067061504904 amp-deoxynojirimycin Adamantane-pentyl-dNM; N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin; AMP-dNM inhibitors inhibits inhibition ceramides lipids glycolipids glucosylceramide synthase glucosylceramidase β-glucosidase 2 glucosidase sphingomyelin deoxynorjirimycin nojirimycin inflammation antiinflammatory anit-inflammatory hapten colitis insulin sensitivity resistance SREBPs sterol genes expression cholesterol HepG2 cells 32.067061504904
580190 ANGPTL6 (human) EIA Kit New - 2012-01-10 117.126734553857 angptl6-human-eia-kit Angiopoietin-like protein 6 kits assays measures measurements angiopoietin-like proteins ANGPTLs angiopoietin-related growth factors AGF ligands regulated regulation angiogenesis glucose lipids energy metabolisms ANGPTL1 ANGPTL2 ANGPTL4 ANGPTL5 ANGPTL3 ANGPTL7 N-terminal N-terminus coiled-coil domains C-terminal C-terminus fibrinogen-like angiopoietins receptors Tie2 proteins Tie1 hepatocytes angiogenesis arteriogenesis ERK1/2-eNOS pathways transgenic mice mouse systemic expenditure high-fat diet-induced obesity ob insulin resistance null diabetic fasting serums levels immunometric sandwich plasma cells cultures supernatants 117.126734553857
13523 Apelin-13 217082-58-1 ≥95% 2010-06-29 54.747371744277 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine Paracrine Protein Factors Paracrine Peptide Factors Growth Factors 54.747371744277
13524 Apelin-36 252642-12-9 ≥95% 2011-04-04 57.321933701657 apelin-36 agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled 57.321933701657
10626 AS-1269574 Exclusive 330981-72-1 ≥98% ✓ 2011-01-17 15.004069981584 as-1269574 diabetes glucose insulin receptors pancrease b-cells b cells .beta.-cells beta-cells β-cells β GPR119 GPR-119 GPR 119 lysophosphatidylcholine LPC oleoylethanol amides OEA agonist Ethanolamines Aminoethanols 15.004069981584
10010266 BAY-11-7082 19542-67-7 ≥98% 2008-07-25 28.859627455494 bay-11-7082 inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 28.859627455494
10009145 Bezafibrate 41859-67-0 >98% 2007-08-02 4.505756906077 bezafibrate Difaterol; Bezatrol; Bezalip; BM 15075; Benzofibrate PPAR PPAR.alpha. PPAR.delta. PPAR.gamma. agonist Pan-PPAR cholesterol atherosclerosis metabolic syndromes LDL HDL proliferator-activated receptors diabetes low-density high-density lipoproteins atherosclerosis cardiovascular PPARa PPARd PPARg endocrinology fibrate 4.505756906077
10489 Candesartan cilexetil 145040-37-5 ≥98% 2011-04-08 8.267679558011 candesartan-cilexetil TCV-116 angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive 8.267679558011
71748 CAY10415 Exclusive 146062-49-9 ≥98% ✓ 2008-07-28 90.883793738489 cay10415 thiazolidinediones TZDs PPARgamma PPARg PPAR.gamma. antidiabetic anti-diabetic insulin blood glucose resistance lipogenesis peroxisome proliferators activated receptors 90.883793738489
10007875 CAY10499 Exclusive 359714-55-9 >98% ✓ 2006-07-25 10.739373848986 cay10499 obesity lipases diabetes triglycerides diacylglycerol inhibitors steroidogenesis spermatogenesis atherosclerosis HSL hormone sensitive endocrinology 10.739373848986
10009079 CAY10506 Exclusive 292615-75-9 ≥98% ✓ 2008-11-17 73.218674033149 cay10506 diabetes glucose metabolism TZDs PPARγ agonists α-lipoic acids anti-diabetic 73.218674033149
10009536 CAY10512 Exclusive 139141-12-1 >97% ✓ 2007-07-18 34.858370165745 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 34.858370165745
10009017 CAY10514 868526-38-9 >98% 2007-01-24 4.201270718232 cay10514 Methyl-8-hydroxy-8-(2-pentyl-oxyphenyl)-oct-5-ynoate peroxisome proliferator-activated receptors aromatics analogs 8-HETEs 8S-HETE 8(S)-HETE agonists PPARa PPARalpha PPAR.alpha. PPARg PPARgamma PPAR.gamma.atherosclerosis 4.201270718232
10012562 CAY10566 944808-88-2 ≥98% 2009-01-07 48.871160220994 cay10566 SCD1 long chain fatty acids monounsaturated type 2 two diabetes dyslipidemia obesity 48.871160220994
10008846 CAY10573 Exclusive 853652-40-1 ≥98% ✓ 2009-02-02 49.886678176795 cay10573 PPARs rosiglitazone diabetes PPARα PPARδ PPARγ 49.886678176795
13143 CAY10587 Exclusive 1082058-99-8 ≥98% ✓ 2009-07-02 23.425359116022 cay10587 free fatty acid receptor1 FFA1 GPR40 pancreatic b-cells glucose insulin diabetes obesity metabolic syndrome receptors 23.425359116022
13282 CAY10599 Exclusive 1143573-33-4 ≥98% ✓ 2009-07-21 48.205131982811 cay10599 thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs 48.205131982811
10009796 CAY10602 374922-43-7 ≥95% 2009-07-15 19.458428483732 cay10602 SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB 19.458428483732
10010250 Cellular Retinol Binding Protein 7 Polyclonal Antibody - 2007-10-16 4.928486187845 cellular-retinol-binding-protein-7-polyclonal-antibody Retinoid Binding Protein 7; cRBP7; RET7; Cellular Retinol Acid-Binding Protein IV western blots WB ICC immunocytochemistry micronutrient cell growth differentiation CRBPs RBP4 RBP7 atherosclerosis blotting immunoblotting IHC immunohistochemistry 4.928486187845
10007171 Cetaben 55986-43-1 ≥98% 2005-11-11 1.840629834254 cetaben Hexadecylamino-p-amino Benzoic Acid clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology 1.840629834254
10011286 Chenodeoxycholic Acid 474-25-9 ≥95% 2009-02-25 25.750209944751 chenodeoxycholic-acid Ulmenide; Kebilis; Anthropodeoxycholic Acid; Hekbilin; Fluibil; CDCA FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA 25.750209944751
13122 CHIR99021 252917-06-9 ≥98% 2011-02-18 78.808571428571 chir99021 CT 99021 GSK-3α GSK-3β inhibitors glucose metabolism insulin diabetes Wnt stem cells mice mouse CHIR-99021 CT-99021 CHIR 99021 CT99021 pyridines glucogen synthesis CHO-IR self-renewal 78.808571428571
10006790 ChREBP Blocking Peptide - 2007-06-06 3.577776243094 chrebp-blocking-peptide WBSCR14; Carbohydrate Response Element-binding Protein proteins diseases WB western blots blotting ICC immunocytochemistry transcription factors nutrients hormonal regulations genes encoding enzymes glucose metabolisms lipogenesis pathways domains nuclear localization signals NLS N-terminus polyprolines basic tissues livers kidneys adipose basal cytosols proteins nucleus dephosphorylations mouse fat HepG2 cells 3.577776243094
10010060 ChREBP Cell-Based Translocation Assay Kit - 2007-08-15 13.511767955800 chrebp-cell-based-translocation-assay-kit Carbohydrate Response Element-Binding Protein Cell-Based Translocation Assay Kit assays kits transcription factors TFs diabetes nutrients hormones hormonal regulation genes encoding enzymes glucose metabolisms lipogenesis dephosphorylated cytoplasm protein Ser196 nucleus liver obesity tolerance drugs discovery modulators sub-cellular localization ICC immunocytochemical stains staining antibody antibodies DyLightTM Pierce Biotechnology Inc. fluorescence fluorescent fluorometric endocrinology cell-based assay cell based assay cba 13.511767955800
10009524 ChREBP DBD (human recombinant) - >85% by SDS-PAGE 2007-04-12 3.440607734807 chrebp-dbd-human-recombinant GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology 3.440607734807
10009753 ChREBP DBD Western Ready Control - 2007-05-03 3.043232044199 chrebp-dbd-western-ready-control Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams Beuren Syndrome Chromosome Region 14 WB western blot western blotting Thr666 PP2A carbohydrate response element CRE L-type pyruvate kinase L-PK glucose Ser196 endocrinology 3.043232044199
71730 Ciglitazone 74772-77-3 ≥98% 55.159568056253 ciglitazone U-63287; ADD 3878 nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology 55.159568056253
700440 Coenzyme A Assay Kit - 2011-01-19 57.320459558434 coenzyme-a-assay-kit CoA Assay Kit kits assays measures measurements coenzymes biosynthesized enzymatic pantothenate vitamin B5 cofactors acyl groups carriers carbonyl-activating TCA cycles fatty acids metabolisms acetates acetyl-CoA acetyl-coenzymes A melatonin heme rat livers diabetes fasting hypolipidemic drugs fat diets tumors plasma serum urine europium chlorides tetracyclines periodic 57.320459558434
580200 CTRP3 (human) EIA Kit New - 2012-01-20 9.183477357510 ctrp3-human-eia-kit Complement C1q TNF-related Protein 3 kits assays EIAs ELISAs enzymes immunoassays measures measurements complements C1q TNF-related tumors necrosis factor-relateds proteins 3 secreted glycoproteins morphogenesis metabolisms cells functions cellular paralog adiponectins adipocytes leukocytes blood chondrogenic differentiations bone cartilage angiogenesis ERF1/2 signaling signalling adipokines mice mouse humans recombinants suppresses suppression hepatic livers glucose sugar C6H12O6 output inhibition inhibits inhibitors gluconeogenesis levels normal ob/ob obese/obese antagonizes lipopolysaccharides LPS toll-like receptors 4 TLR4 competitive serums plasmas cultures supernatants 9.183477357510
580120 CTRP5 (human) EIA Kit - 2011-08-02 16.628242019643 ctrp5-human-eia-kit C1QTNF; C1q tumor necrosis factor-α-related proteins C1q/tumors necrosis factors 5 superfamily genes untranslated membranes frizzled-related proteins MFRP bicistronic transcript mutations late-onset retinal degeneration LORD apical basal pigmented epithelium ciliary tissues neuroectodermal macular adipose blood glycoproteins trimers oligomeric complexes disulfide bonds N-terminal N-terminus cysteine residues extracellular recombinant activator adenosine monophosphates AMP-activated kinases AMPK cells GLUT4 glucose uptake serum obese diabetic mice mouse competitive plasma assays kits measures measurements EIAs ELISAs enzymes immunoassays 16.628242019643
700520 D-Lactate Assay Kit - 2011-02-23 73.609932428945 d-lactate-assay-kit kits assays measures measurements D(-)-Lactates stereoisomers blood exogenous fermented foods yogurt sauerkraut pickles gastrointestinal tract lactobacilli bifidobacteria cytosols cells glyoxylase I II pathways methylglyoxal glutathione S-D-lactoylglutathione L-lactate L(+)-lactate pyruvates dehydrogenases LDH liver D-a-hydroxy acid D-alpha-hydroxy D-α-hydroxy mammals enzymes humans murines mitochondrial mitochondria D-lactic acidosis metabolic serum neurotoxic fermentation carbohydrates kidneys short bowel syndromes jejunoileal bypass surgery diabetes infection ischemia trauma monogastric malabsorptive nutrient sepsis plasma urine saliva intracellular extracellular cell culture samples oxidation reduction NAD+ NADH 73.609932428945
700210 DPP (IV) Inhibitor Screening Assay Kit - 2009-05-27 99.871827424800 dpp-iv-inhibitor-screening-assay-kit Dipeptidyl exopeptidases IV DPPIV DPP4 enzymes CD26 cluster of differentiation T-cells activation antigens adenosine deaminase complexing 2 membrane-bound glycoproteins immune regulation signal transduction apoptosis kidneys small intestines placentas humans serums seminal fluids proteolytic derivatives serines X-prolines X-alanines dipeptides N-terminus N-terminal polypeptides growth factors chemokines neuropeptides vasoactive inhibitors inhibits inhibition oral antidiabetic agents glucose homeostasis glucoregulatory hormones glucose-dependent insulinotropics GIP glucagon-like peptide-1 GLP-1 gastric therapeutics Type 2 tumors cancers markers neoplasms assays kits measures measurements fluorescences fluorescent fluorogenics substrates Gly-Pro-Aminomethylcoumarin AMC 99.871827424800
500480 dsDNA Autoantibody (human) EIA Kit New - 2011-10-07 0E-12 dsdna-autoantibody-human-eia-kit Anti-double stranded DNA EIA EIAs ELISAs enzymes immunoassays kits measures measurement autoimmunity neutrophils extracellular traps NETs histones peptides deoxyribonucleic acids DNAse I-mediated DNA-degrading plasma systemic lupus erythematosus SLE autoantibodies double stranded dsDNA IgG anti-dsDNA autoimmune diseases immunometric isotypes human serum affinity-purified antibody calf thymus poly-L-lysine protamine sulfate 0E-12
10011296 (E)-Guggulsterone 39025-24-6 ≥98% 2009-12-03 0E-12 -e-guggulsterone anti-flammatory cancers FXR bile acids LDL cholesterol antiinflammatory atherosclerosis obesity diabetes inflammation farnesoid X receptors guggul trees 0E-12
10008884 Eicosapentaenoic Acid ethyl ester 86227-47-6 ≥98% 2009-01-29 56.964121546962 eicosapentaenoic-acid-ethyl-ester EPA-EE; EPA ethyl ester fish oils anti-inflammatory anitinflammatory cardiovascular polyunsaturated fatty acids PUFAs EPAs nutrition oxidation competitive inhibitors inhibits inhibition metabolism cholesterol triglycerides insulin resistance adiponectin high fat diet high-fat TNFα 56.964121546962
10010019 FABP2 Polyclonal Antibody - 2007-10-02 24.779798737174 fabp2-polyclonal-antibody Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2; I-FABP WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting 24.779798737174
10009549 FABP4 (human recombinant) - >90% 2007-06-15 32.261976200594 fabp4-human-recombinant A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 32.261976200594
9001068 FABP4 (human recombinant) FITC conjugated New - ≥95% 2011-08-23 11.593022888713 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 11.593022888713
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 5.691125690607 fabp4-human-recombinant-western-ready-control A-FABP; FABP4; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4 fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 5.691125690607
10005191 FABP4 (mouse recombinant) - >95% 2005-07-27 11.970839779005 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 11.970839779005
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 6.356127992633 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 6.356127992633
10004888 FMOC-L-Leucine 35661-60-0 ≥98% 2010-07-19 35.840871228219 fmoc-l-leucine FMOC-Leu; NPC 15199; NSC 334290 peroxisome proliferator-activated proliferator activated receptors activates PPAR PPARg PPAR-g PPARgamma PPAR.gamma. PPAR-gamma PPAR-.gamma. PPARγ PPAR-γ PPAR γ adipocytes differentiation fatty acids uptake glucose metabolism agonist partial insulin resistance diabetes adipogenesis NPC15199 NSC334290 NPC-15199 NSC-334290 Leucine L-Isomer Leucine L Isomer L-Isomer Leucine L-LeucineLeucine 35.840871228219
700310 Free Fatty Acid Assay Kit - 2010-09-08 108.971596852363 free-fatty-acid-assay-kit FFA kits assays measures measurements acids triglycerides intestines hydrolyzed glycerols enzymes pancreas pancreatic lipases intestinal liposomes capillaries lymph systems blood plasmas serums hepatocytes adipocytes muscles fibers oxidized sugars glucagon fats proteins albumin FFA skeletal skeletons hearts livers pathophysiological obesity insulin resistance type 2 II diabetes pathogenesis insulin-stimulated peripheral glucose uptake beta cells oxidative stressproinflammatory effects NFκB nuclear factors inflammation resistances metabolic urine enzymatic reactions Acyl CoA synthetase ACS acylation coenzymes oxidases ACOD hydrogen peroxides H2O2 horseradish peroxidases HRP 10-aceyl-3,7-dihydroxyphenozazine ADHP fluorescence fluorescent resorufins 108.971596852363
11104 Fructose 1,6-bisphosphatase (human recombinant) New - ≥95% 2011-11-29 86.670151783932 fructose-1-6-bisphosphatase-human-recombinant FDPase; FBP1; F1,6BPase metabolism insulin non-insulin-dependent type 2 diabetes mellitus glucose kinases fructose 1,6-diphosphatase liver enzymes gluconeogenesis phosphofructokinase glycolysis lactate glycerol alanine NIDDM hyperglycemia 86.670151783932
10816 FTO (human) Monoclonal Antibody (Clone FT 86-4) - 2011-06-15 0E-12 fto-human-monoclonal-antibody-clone-ft-86-4 Fat Mass- and Obesity-associated Protein; FATSO antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP genes mutation metabolic syndrome genotype type 2 diabetes FT 864 FT864 0E-12
10815 FTO (mouse) Monoclonal Antibody (Clone FT 342-1) - 2011-06-15 0E-12 fto-mouse-monoclonal-antibody-clone-ft-342-1 Fat Mass- and Obesity-associated Protein; FATSO antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay mouse mice genes mutation metabolic genotype type 2 diabetes FT 3421 syndrome FT3421 0E-12
10814 FTO (murine) Monoclonal Antibody (Clone FT 62-6) - 2011-06-14 0E-12 fto-murine-monoclonal-antibody-clone-ft-62-6 Fat Mass- and Obesity-associated Protein; FATSO antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP mouse mice genes mutation metabolic genotype type 2 diabetes syndrome FT 626 FT626 0E-12
13068 Fucoxanthin Exclusive 3351-86-8 ≥98 ✓ 2010-01-29 14.214254143646 fucoxanthin α-Carotene carotenoids algae white adipose tissues WAT obesity weight gain uncoupling proteins 1 UCP1 thermogenesis diabetes type 2 glucose insulin all-trans Carotenoids Xanthophyll Xanthophyll Carotenoids Xanthophyllshyperinsulinemia 14.214254143646
10010622 Genipin 6902-77-8 ≥98% 2008-05-09 97.871961325967 genipin (+)-Genipin obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity 97.871961325967
10990 Glucokinase (human liver recombinant) New - ≥85% 2011-09-08 47.324854833327 glucokinase-human-liver-recombinant Hexokinase D; Human Hexokinase IV isoform 2; ATP:D-Hexose 6-Phosphotransferase GCK metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases GCK ATP-dependent phosphorylation glycolytic liver tissues neurons pancreatic cells pituitary endocrine hexokinases mutations 47.324854833327
10989 Glucokinase (human pancreatic recombinant) New - ≥90% 2011-09-08 49.302483468673 glucokinase-human-pancreatic-recombinant Hexokinase D; ATP:D-Hexose 6-Phosphotransferase GCK; Human Hexokinase IV isoform 1 metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases GCK ATP-dependent phosphorylation glycolytic liver tissues neurons pancreatic cells pituitary endocrine hexokinases mutations 49.302483468673
700300 Glucose-6-Phosphate Dehydrogenase Activity Assay Kit - 2011-07-28 88.789759425657 glucose-6-phosphate-dehydrogenase-activity-assay-kit G6PDH Activity Assay Kit kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent 88.789759425657
10009582 Glucose Assay Kit - 2007-06-11 176.589724567020 glucose-assay-kit assays kits monosaccharides simple sugars carbohydrates blood stream energy cells hyperglycemia hypoglycemia Diabetes mellitus oxidase-peroxide d-gluconolactone delta-gluconolactone .delta.-gluconolactone plasma serum urine endocrinology 176.589724567020
600470 Glucose Uptake Cell-Based Assay Kit New - 2011-12-14 110.167632176042 glucose-uptake-cell-based-assay-kit assay kits measuring measurement CBAs C6H12O6 energy metabolisms adenosines triphosphates ATP cells homeostasis intestines blood muscles liver glycogens hydrolyzed levels transporters concentrations gradients energy-dependent uptakes gut kidneys rate hormones human growth factors insulin proliferation atrophy cancers pathways aerobic glycolysis anti-cancer effects drugs discovery fluorescent analogs 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose 2-NBDG modulators cellular deoxyglucose cultured apigenin flavonoid 110.167632176042
700720 Glycerol Fluorometric Assay Kit New - 2012-01-17 127.788861351381 glycerol-fluorometric-assay-kit assays kits measures measurements flourometer fluorometry triglycerides storage fats metabolites energy metabolisms oxidations physiological pathological hydrolyzed free fatty acids FFAs blood glucose sugar gluconeogenesis lipolysis serums concentrations kinases x-linked inborn hyperglycerolemia glyceroluria fluorescence-based plasma phosphorylated glycerol-3-phosphates G-3-P adenosine-5'-diphosphates ADP oxidized phosphates oxidases dihydroxyacetones hydrogen peroxides H2O2 horseradish HRPs 1-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin 127.788861351381
700480 Glycogen Assay Kit - 2011-08-02 78.294898650517 glycogen-assay-kit kits assays measures measurements polysaccharides storage glucose animal human cells polymers alpha(1,4) .alpha.(1,4) α(1,4) linkages units backbones livers muscles glycogenesis glycolysis brains stomachs granules cytosols cycles hepatocytes source available glucose-6-phosphatases blood kidneys glial WBCs white uterus pregnancy embryo abnormal metabolisms diabetes mellitus synthesis storage diseases von Gierke's Pompe McArdle's tissues hydrolyzed hydrolysis amyloglucosidases .beta.-D-glucose beta-D-glucose β-D-glucose oxidized oxidases hydrogen peroxides H2O2 horseradish peroxidases HRP 10-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin 78.294898650517
10007206 GPR40 Blocking Peptide - 2007-04-12 3.187790055248 gpr40-blocking-peptide immunohistochemistry peptide insulin diabetes breast cancer 3.187790055248
10007205 GPR40 Polyclonal Antibody - 2007-04-04 15.848747697974 gpr40-polyclonal-antibody Free Fatty Acid Receptor; FFAR1; G Protein-Coupled Receptor 40 immunohistochemistry antibody insulin diabetes breast cancer endocrinology IHC 15.848747697974
10009374 GSK3β (Phospho-Ser9) Polyclonal Antibody - 2006-11-13 2.362074892572 gsk3-phospho-ser9-polyclonal-antibody Anti-Phospho-Ser9 Glycogen Synthase Kinase 3β antibodies proteins diseases antibodies antisera antiserum WB western blots blotting serine/threonine kinases regulation regulates signaling pathways GSK3a GSK3alpha GSK3.alpha. GSK3b GSK3beta inhibitors inhibition inhibits insulin Wnt Ser9 phosphorylation phospho-specific immunoblotting 2.362074892572
10008907 GW 9508 885101-89-3 ≥98% 2007-05-14 41.137430939226 gw-9508 agonists GPR40 GPR120 G protein receptors fatty acid glucose insulin MIN6 coupled endocrinology GW9508 41.137430939226
10011211 GW 9578 Exclusive 247923-29-1 ≥98% ✓ 2008-05-23 22.652014449638 gw-9578 atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated 22.652014449638
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 69.372228360957 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 69.372228360957
10010324 Harmine 442-51-3 ≥98% 2007-11-07 24.696001143074 harmine metabolic syndromes obesity diabetes PPAR.gamma. insulin sensitivity metabolism .beta.-carboline b-carboline alkaloids hyperglycemia signalling pathway inflammatory gene expression endocrinology 24.696001143074
11512 HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New - 2012-01-16 145.000000000000 hmgb1-monoclonal-antibody-clone-img19n10b7 High Mobility Group Protein B1; HMG1 high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB 145.000000000000
11514 HMGB1 Monoclonal Antibody (Clone IMG19N12A1) - 85.000000000000 hmgb1-monoclonal-antibody-clone-img19n12a1 High Mobility Group Protein B1; HMG1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 85.000000000000
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 145.000000000000 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 145.000000000000
11515 HMGB1 Polyclonal Antibody (aa 100-150) New - 2012-01-20 148.333333333333 hmgb1-polyclonal-antibody-aa-100-150 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 148.333333333333
11516 HMGB1 Polyclonal Antibody (aa 25-75) New - 2012-01-30 156.666666666667 hmgb1-polyclonal-antibody-aa-25-75 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 156.666666666667
500340 Human Serum Albumin EIA Kit - 2009-07-16 104.488519337016 human-serum-albumin-eia-kit Albumin (human serum) EIA Kit; HSA ELISA Kit solid plates EIAs ELISAs enzymes immunoassays kits measures measurement renal kidneys blood proteins serums osmotic pressure buffering pH hormones fatty acids transports transportation microaluminuria macroalbuminuria disease non-diabetic nephropathy cardiovascular morbidity mortality creatinine assays 104.488519337016
10010676 Hydrochlorothiazide-d2 15N2 - ≥99% deuterated product 2009-05-02 0E-12 hydrochlorothiazide-d2-15n2 58-93-5 8049-49-8 125727-50-6 edema hypertension diabetes deuterated deuterium 0E-12
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 9.354198895028 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes 9.354198895028
10010785 (±)-Lisofylline 6493-06-7 ≥98% 2009-09-18 17.310372928177 -lisofylline CT-1501R; BL 194; LSF pentoxifylline phosphatidic acids shock sepsis antiinflammatory anti-inflammatory insulin diabetes IL-12 IL-12 inhibits inhibitions inhibitors IFN-γ IFNγ β-cell cell 39476-38-5 151852-35-3 17.310372928177
700510 L-Lactate Assay Kit - 2011-02-21 113.387592201590 l-lactate-assay-kit kits assays measures measurements L(+)-lactates stereoisomers humans metabolisms pyruvates ratios redox reduction oxidation cells NAD+ NADH dehydrogenases LDH glycolysis oxygen Cori cycles livers monocarboxylates tissues skeletal cardiac muscles kidneys substrates feedback inhibition lactic acidosis exercise convulsions sepsis respiratory failure HIV cancers diabetes serum plasma blood urine saliva intracellular extracellular cell culture samples 113.387592201590
10010236 ML-9 105637-50-1 ≥98% 2008-01-21 16.362486187845 ml-9 PKB Akt inhibitors inhibits inhibition serine/threonine kinase PKA P90S6 MAP kinases cancers anti-cancers insulin glucose transports calcium channels calmodulin intracellular smooth muscles asthma 16.362486187845
10009661 N-Octadecyl-N'-propyl-sulfamide - >95% 2008-04-23 5.244116022099 n-octadecyl-n-propyl-sulfamide PPAR.alpha. PPARa PPARalpha OEA satiety obesity metabolism food intake triglyceride lipids activators appetite suppression 5.244116022099
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 0.869820441989 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 0.869820441989
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 1.019337016574 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 1.019337016574
13804 OU749 519170-13-9 ≥95% 2010-07-20 1.839779005525 ou749 γ-Glutamyl transferases γ-glutamyl transpeptidases glutathione markers liver dysfunction alcohol abuses biomarkers diabetes cardiovascular diseases cancers acivicin OU-749 OU 749 Mixtures Sulfonamide Sulfonamide Mixtures Sulfonamides 1.839779005525
10010374 p38 MAPK (Phospho-Thr180/Tyr182) Cell-Based Phosphorylation/Translocation Assay Kit - 2007-09-17 2.455406471981 p38-mapk-phospho-thr180-tyr182-cell-based-phosphorylation-translocation-assay-kit phosphorylation kits assays enzymes diseases asthma autoimmunity stress response nervous system fluorescence fluorescent fluorometric 2.455406471981
10218 PCSK9 Monoclonal Antibody (Clone 15A6) - 2008-10-29 12.235893186004 pcsk9-monoclonal-antibody-clone-15a6 Proprotein Convertase Subtilisin Kexin 9; NARC-1 antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots 12.235893186004
10010254 Pentosidine 124505-87-9 ≥98% 2011-02-10 19.966132596685 pentosidine advanced glycation end products AGEs RAGE glycosylation diabetes uremia aging rheumatic arthritis biomarkers 19.966132596685
10004943 PEPCK Polyclonal Antibody - 2005-08-03 36.316895027624 pepck-polyclonal-antibody PEPCK-c; Pck1; Phosphoenolpyruvate carboxykinase proteins antibodies antisera antiserum WB western blots blotting hormones regulates enzymes steps gluconeogenesis catalyzing conversions oxaloacetate phosphoenolpyruvate mRNA liver kidney cortex white adipose tissue brown fat mammary gland lactation small intestine non-insulin-dependent diabetes mellitus streptozotocin-induced elevated activity isozymes cytosolic mitochondrial murine mouse rat endocrinology immunoblotting 36.316895027624
301707 PGC-1 Blocking Peptide - 2006-07-25 16.098563535912 pgc-1-blocking-peptide antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases proteins peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity 16.098563535912
101707 PGC-1 Polyclonal Antibody - 2005-10-12 29.404158714214 pgc-1-polyclonal-antibody PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting 29.404158714214
71745 Pioglitazone 111025-46-8 >98% 41.951823204419 pioglitazone PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated rosiglitazone receptors activation selectively selectivity 41.951823204419
10028 Pioglitazone (potassium salt) - >98% 52.797395422257 pioglitazone-potassium-salt PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated receptors 52.797395422257
13643 PP242 1092351-67-1 ≥95% 2011-04-22 25.947510304305 pp242 mTORs mTORC1 mTORC2 inhibitors cancer leukemia rapamycin PP 242 PP-242 inhibited inhibition 25.947510304305
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 27.630773480663 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 27.630773480663
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 20.984726826273 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 20.984726826273
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 58.741270718231 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 58.741270718231
10007685 PPARγ FP-Based Ligand Screening Assay Kit - Green - 2009-07-16 42.093284781517 ppar-fp-based-ligand-screening-assay-kit-green Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists 42.093284781517
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 18.920466543891 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 18.920466543891
10006247 PPARδ Blocking Peptide - >70% 2004-11-09 4.339226519337 ppar-blocking-peptide PPARβ; Peroxisome Proliferator-activated Receptor δ; NR1C2 controls peptides western blots WB immunoblotting antibodies receptors PPARbeta PPAR.beta. lipid metabolism obesity special:month specialdiscount:15 specialstart:2008-02-01 specialend:2008-02-29 4.339226519337
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 11.193658686310 ppar-human-recombinant PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 11.193658686310
101720 PPARδ Polyclonal Antibody - 2004-11-05 18.912511300853 ppar-polyclonal-antibody Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies 18.912511300853
13000 Pterostilbene 537-42-8 ≥98% 2009-09-09 32.300789265982 pterostilbene 3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory 32.300789265982
13346 Rapamycin 53123-88-9 ≥95% 2009-10-21 74.028345951845 rapamycin Sirolimus immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases 74.028345951845
579070 Retinol Binding Protein 4 (human) Competitive EIA Kit - 2011-08-01 9.183477357510 retinol-binding-protein-4-human-competitive-eia-kit RBP4 binding proteins EIAs ELISAs enzymes immunoassays kits measures measurement insulin glucose homeostasis uptake skeletal muscles adipose tissues transporter 4 GLUT4 resistance vitamins A adipokines metabolic obesity syndromes cardiovascular diseases expression pro-inflammatory cytokines LDLs low-density lipoproteins cholesterols diet-induced obese hyperlipidemic hyperlipidemia dyslipidemia lipids metabolisms serums plasmas disorders 9.183477357510
13616 (R)-Lisofylline 100324-81-0 ≥98% 2010-05-27 1.784944751381 -r-lisofylline (R)-LSF; (-)-Lisofylline pentoxifylline phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes interleukins 12 IL IFN-gamma 1.784944751381
13300 Ro 31-6045 113963-68-1 ≥98% 2009-07-28 4.430248618784 ro-31-6045 Bisindolylmaleimide V PKC kinase inhibitors S6K mitogen-stimulated proteins p70 p85 protein kinases C 4.430248618784
71740 Rosiglitazone 122320-73-4 >98% 141.594325177584 rosiglitazone BRL 49653 BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome atherosclerosis endocrinology 141.594325177584
10011343 Rosiglitazone-d5 Maleate - >99% deuterated product 2009-04-04 40.281524861878 rosiglitazone-d5-maleate SPI TZDs thiazolinedions PPARg PPAR.gamma. PPARgamma selective ligand insulin resistance anti-inflammatory 40.281524861878
71742 Rosiglitazone (potassium salt) 316371-84-3 >98% 100.863319939728 rosiglitazone-potassium-salt BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome salts thiazolidinediones atherosclerosis endocrinology 100.863319939728
10010247 SB 415286 264218-23-7 ≥98% 2008-10-29 8.411187845304 sb-415286 GSK3 GSK-3 PI3K signaling PI3K signalling glycogen synthase inhibitors inhibits inhibition neuron survival glycogen synthesis Chang human liver cells line potent selective sb415286 8.411187845304
10007682 Serum Retinol Binding Protein 4 Blocking Peptide - 2007-07-30 0E-12 serum-retinol-binding-protein-4-blocking-peptide pRBP Blocking Peptide; Plasma Retinol Binding Protein 4 Blocking Peptide; sRBP4 Blocking Peptide wb western blotting TTR serum type 2 diabetes sRBP plasma SRBP-4 blots proteins serums retinols insulin special:month specialdiscount:15 specialstart:2007-08-01 specialend:2007-09-30 RBP 0E-12
10007818 Serum Retinol Binding Protein 4 (human recombinant) - ≥95% 2006-10-05 14.274822415153 serum-retinol-binding-protein-4-human-recombinant RBP4; sRBP4 proteins vitamin A blood mammals .beta.-sheet-rich lipocalins hepatocytes plasma tetrameric transthyretin TTR adipocyte-derived adipocytes signaling type 2 diabetes insulin C-terminal terminus hexahistidine tag endocrinology 14.274822415153
10007681 Serum Retinol Binding Protein 4 Polyclonal Antibody Exclusive - ✓ 2007-08-03 3.547999999999 serum-retinol-binding-protein-4-polyclonal-antibody Plasma Retinol Binding Protein 4; pRBP; sRBP4 vitamin A wb western blotting type 2 diabetes lipocalin TTR transthyretin sRBP4 sRBP-4 proteins adipocytes signals signalling signaling insulin blots retinols serums RBP atherosclerosis endocrinology immunoblotting 3.547999999999
10009754 Serum Retinol Binding Protein Western Ready Control Exclusive - ✓ 2008-07-08 0E-12 serum-retinol-binding-protein-western-ready-control sRBP4; RBP4 proteins C-terminal western blots immunoblotting WB SRBPs hexahistidine His-tag His-tagged insulin resistance tyep 2 diabetes pathogenesis blotting 0E-12
13617 (S)-Lisofylline Exclusive 100324-80-9 ≥98% ✓ 2010-05-27 1.493646408840 -s-lisofylline (S)-LSF; (+)-Lisofylline pentoxifyllines phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes antiinflammatory inflammatory inflammation inflammed 1.493646408840
10011671 Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit - 2009-02-24 23.239996419071 soluble-epoxide-hydrolase-inhibitor-screening-assay-kit sEH Inhibitor Screening Assay Kit epoxides hydrolases sEHs inhibits inhibition assays kits fluorescence-based catalyzes hydrolysis exogenous endogenous vicinal diols substrates EETs epoxyeicosatrienoic acids vasodilatory vasodilation anti-inflammatory molecules therapy therapeutics hypertension vascular diseases PHOME (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester 6-methoxy-2-naphthaldehyde excitation emission wavelengths a/b-hydrolases alpha/beta-hydrolases .alpha./.beta.-hydrolases enzymes homodimers C-terminal C-terminus animals models cyanohydrins cyanide ions 23.239996419071
10009239 SREBP-2 Cell-Based Translocation Assay Kit - 2007-04-17 33.036951094740 srebp-2-cell-based-translocation-assay-kit Sterol Regulatory Element-Binding Protein-2 Cell-Based Translocation Assay Kit sterol regulatory element binding proteins athersclerosis cholesterols fatty acids triglycerides phospholipids helix-loop-helix HLH transcription factors DyLight Pierce Biotechnology assays fluorescence fluorescent fluorometric cell-based assays cell based assay cba U18666A U 18666A U-18666A 33.036951094740
10009749 SREBP-2 Western Ready Control - 94 kDa (GST-tagged); 68 kDa (native) 2007-07-30 14.452685082873 srebp-2-western-ready-control Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2 WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis 14.452685082873
10026 T0070907 313516-66-4 >98% 64.927204419889 t0070907 T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology 64.927204419889
10010303 Triglyceride Colorimetric Assay Kit - 2007-10-31 264.593995717813 triglyceride-colorimetric-assay-kit assays kits triglycerides enzymes enzymatic hydrolysis water-insoluble lipids three fatty acids esterified glycerols blood serums lipoproteins chylomicrons very low density VLDLs dietary fats metabolisms energy diagnosis primary secondary hyperlipoproteinemia dyslipidemia triglyceridemia diabetes mellitus nephrosis livers obstruction endocrine colorimetric fluorometric plasmas coupled reaction systems 264.593995717813
700730 Triglyceride Fluorometric Assay Kit New - 2012-01-17 124.091327136133 triglyceride-fluorometric-assay-kit assays kits measures measurements flourometer fluorometry triglycerides water-insoluble lipids fatty acids esterified glycerols blood lipoproteins chylomicrons very low-density VLDLs dietary fats hydrolyzed hydrolysis free FFAs monoglycerides diglycerides intestines intestinal villi guts resynthesized capillary beds lipases adipose tissues storage stream oxidized mitrochondrias peroxisomes energy metabolisms levels lipids primary secondary hyperlipoproteinemia dyslipidemia triglyceridemia diabetes mellitus nephrosis livers obstructions endocrine disorders enzymatic hydrolysis fluorescence-based plasmas serums phosphorylated glycerol-3-phosphates G-3-P adenosine-5'-diphosphates ADP oxidized phosphates oxidases dihydroxyacetones hydrogen peroxides H2O2 horseradish HRPs 1-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin 124.091327136133
71750 Troglitazone 97322-87-7 >98% 163.927613259668 troglitazone ResulinTM antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology 163.927613259668
10010245 U-83836E 137018-55-4 ≥98% 2008-07-08 0.160220994475 u-83836e antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 PNU-83836E PNU83836E 0.160220994475
700320 Uric Acid Assay Kit - 2010-08-30 117.223640619399 uric-acid-assay-kit Urate Assay Kit kits assays measures measurement acids human purines metabolisms urine serum renal excretion excreted allantoin enzymes urate oxidases uricase genes obesity alcohol consumption hyperuricemia gout kidney stones metabolic syndromes hypertension cardiovascular diseases exercise-induced acute failure hypouricemia 117.223640619399
579000 Vaspin (human) EIA Kit - 2011-05-26 28.823064252096 vaspin-human-eia-kit Visceral Adipose Tissue-Derived Serpin A12 kits measures measurements EIA enzymes immunoassays adipokines insulin-sensitizing cDNA deoxyribonucleic acids white adipose tissues obese Otsuka Long Evans Tokushima Fatty OLETF rats absominal obesity type 2 diabetes serpins b-sheets beta-sheets β-sheets α-helices a-helices alpha-helices reactive site loops cognate serine proteases mRNA messenger ribonucleic visceral serum resistance pioglitazone biomarker plasma cells culture supernatants 28.823064252096
10010591 Wortmannin 19545-26-7 ≥98% 2008-11-21 41.226538697643 wortmannin KY 12420 phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK 41.226538697643
13576 YM-201636 371942-69-7 ≥95% 2010-04-14 6.829607734806 ym-201636 PIKfyve phosphoinositide kinase PIK zinc finger domains phosphatidylinositol 3-phosphate PI3P PI(3,5)P2 membrane trafficking cytoskeleton inhibitors endosomal trafficking endosomes phagocytosis retrovirus virology adipocytes insulin glucose diabetes YM201636 YM 201636 Aminopyridines 6.829607734806
10009992 Zeaxanthin 144-68-3 ≥98% 2009-02-02 20.135709023940 zeaxanthin Zeaxanthol; Xanthophyll 3; Anchovyxanthin carotenoid degeneration AMDs luteins diabetes antioxidant oxidative injury injuries VEGFs macula 20.135709023940
71800 (Z)-Guggulsterone 39025-23-5 ≥98% 2009-12-01 0.167679558011 -z-guggulsterone anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt 0.167679558011
700190 β-Hydroxybutyrate (Ketone Body) Assay Kit - 2009-06-02 154.003509703923 -hydroxybutyrate-ketone-body-assay-kit β-HB Assay Kit; 3-Hydroxybutyric Acid Assay Kit .beta.-hydroxybutyrate beta-hydroxybutyrate b-hydroxybutyrate b-HB beta-HB .beta.-HB β-HB 3-hydroxybutyric acids ketones body bodies acetoacetates acetones ketosis lipids metabolisms fasting exercise diets diabetes childhood hypoglycemia corticosteroids growth hormones deficiency intoxication alcohols salicylates organ failure ketoacidosis metabolic acidosis blood serums subclinical glucose diabetic coma hyperosmolar non-ketotic insulin hyperketonemia neurodegenerative diseases inhibits inhibition adipocytes lipolysis plasmas urine assays 154.003509703923
10007602 Δ2-cis Eicosenoic Acid 93772-82-8 ≥98% 2006-01-04 0E-12 -2-cis-eicosenoic-acid .alpha.,.beta.-unsaturated fatty acids a,b-unsaturated synthesis .DELTA.2-trans D2 extracted fresh wateer clams medical medicinal diabetes lipids metabolisms 2-octadecenoic livers blood sugars streptozocin-induced rats 0E-12
10007622 Δ2-trans Eicosenoic Acid - ≥98% 2006-01-04 0E-12 -2-trans-eicosenoic-acid .alpha.,.beta.-unsaturated fatty acids a,b-unsaturated synthesis .DELTA.2-cis D2 medical medicinal diabetes lipids metabolisms 2-octadecenoic livers blood sugars streptozocin-induced rats 0E-12
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?